Allied Biotech Corporation
1780
Rank in Stocks
#20769
Allied Biotech Corporation operates as a global producer and supplier... Allied Biotech Corporation operates as a global producer and supplier specializing in carotenoids. The company's diverse product portfolio features key carotenoids such as: Beta-Carotene, known for imparting vibrant yellow to reddish-orange hues across numerous applications. Beta-Apo-8'-Carotenal, a versatile food colorant delivering shades from rich orange to deep red. Lycopene, a valuable nutrient that provides striking red tones for incorporation into food, dietary supplements, and pharmaceutical formulations. Canthaxanthin, which contributes reddish-orange colors specifically to food and beverage products. Lutein, another carotenoid frequently derived from or associated with green leafy vegetables (like spinach, kale, and broccoli) and egg yolks. Additionally, Allied Biotech offers Nano Coenzyme Q10, an antioxidant crucial for cellular energy production. The corporation caters to a diverse clientele across the food, beverage, dietary supplement, and animal feed sectors. Established in 2001, Allied Biotech Corporation maintains its headquarters in Taipei, Taiwan.
Share Price
$0.72248167
Last synced: 2026-11-10
Market Cap
$78.80M
Change (1 day)
-0.42%
Change (1 year)
20.39%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Allied Biotech Corporation (1780)
Category
Healthcare
EPS for Allied Biotech Corporation (1780)
EPS as of June 2026 TTM: $0.09
According to Allied Biotech Corporation's latest financial reports, its current EPS (TTM) is $0.09. At the end of 2025 the company had an EPS of $0.04, an increase over its 2024 EPS of $0.03.
EPS history for Allied Biotech Corporation from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.09 | 127.75% |
| 2025 | $0.04 | 33.44% |
| 2024 | $0.03 | -3.61% |
| 2023 | $0.03 | -33.86% |
| 2022 | $0.05 | 884.31% |
| 2021 | $0.01 | -82.94% |
| 2020 | $0.03 | -20.90% |
| 2019 | $0.04 | -18.00% |
| 2018 | $0.05 | 82.21% |
| 2017 | $0.03 | 90.23% |
| 2016 | $0.01 | -10.74% |
| 2015 | $0.01 | 577.27% |
| 2014 | 0.00 | -4.35% |
| 2013 | 0.00 | -84.14% |
| 2012 | $0.01 | 173.58% |
| 2011 | $0.01 | 0.00% |
| 2010 | 0.00 | -100.00% |
| 2009 | 0.00 | 58.33% |
| 2008 | 0.00 | -106.38% |
| 2007 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 7,036.55% |
DE
|
|
| $6.08 | 6,571.35% |
DE
|
|
| $1.55 | 1,602.09% |
JP
|
|
| $3.66 | 3,917.56% |
CH
|
|
| $0.45 | 393.96% |
IL
|
Questions about Allied Biotech Corporation's earnings per share (EPS)
What is Allied Biotech Corporation's earnings per share (EPS)?
Allied Biotech Corporation's earnings per share (EPS) over the last twelve months is $0.09, as of Jun 2026.
What was Allied Biotech Corporation's earnings per share (EPS) in 2025?
In 2025, Allied Biotech Corporation's earnings per share (EPS) was $0.04, 33.33% more than in 2024 ($0.03).
How has Allied Biotech Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Allied Biotech Corporation's earnings per share (EPS) went from $0.03 to $0.04, an average growth of 5.92% a year.
How does Allied Biotech Corporation's earnings per share (EPS) compare with similar companies?
Allied Biotech Corporation's earnings per share (EPS) ($0.09) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.